96 related articles for article (PubMed ID: 2322471)
21. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells.
Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K
J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581
[TBL] [Abstract][Full Text] [Related]
22. Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas.
Kuroda K; Yamashina K; Kitatani N; Kagishima A; Hamaoka T; Hosaka Y
Immunology; 1995 Jan; 84(1):153-8. PubMed ID: 7890298
[TBL] [Abstract][Full Text] [Related]
23. The murine MHC class I genes, H-2Dq and H-2Lq, are strikingly homologous to each other, H-2Ld, and two genes reported to encode tumor-specific antigens.
Lee DR; Rubocki RJ; Lie WR; Hansen TH
J Exp Med; 1988 Nov; 168(5):1719-39. PubMed ID: 3263465
[TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
25. Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes.
Hämmerling GJ; Klar D; Katzav S; Segal S; Feldman M; Wallich R; Hämmerling A
J Immunogenet; 1986; 13(2-3):153-7. PubMed ID: 3819449
[TBL] [Abstract][Full Text] [Related]
26. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
Weber JS; Rosenberg SA
Cancer Res; 1988 Oct; 48(20):5818-24. PubMed ID: 3139284
[TBL] [Abstract][Full Text] [Related]
27. Mice transgenic for a gene that encodes a soluble, polymorphic class I MHC antigen.
Hunziker R; Margulies DH
Biotechnology; 1991; 16():175-85. PubMed ID: 2007189
[No Abstract] [Full Text] [Related]
28. Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma.
Stauss HJ; Linsk R; Fischer A; Watts S; Banasiak D; Haberman A; Clark I; Forman J; McMillan M; Schreiber H
J Immunogenet; 1986; 13(2-3):101-11. PubMed ID: 2880914
[TBL] [Abstract][Full Text] [Related]
29. MHC class I gene organization in > 1.5-Mb YAC contigs from the H2-M region.
Jones EP; Xiao H; Schultz RA; Flaherty L; Trachtulec Z; Vincek V; Larin Z; Lehrach H; Lindahl KF
Genomics; 1995 May; 27(1):40-51. PubMed ID: 7665183
[TBL] [Abstract][Full Text] [Related]
30. Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
Gaforio JJ; Pérez M; Algarra I; Mialdea MJ; Ljunggren HG; Garrido F
Int J Cancer; 1991 Dec; 49(6):906-10. PubMed ID: 1959995
[TBL] [Abstract][Full Text] [Related]
31. Differential lack of class I H-2d antigen expression by sublines of the BALB/c S49 T cell lymphoma.
Joseph LJ; Levy E; Ozato K; Hochman J; Shearer GM
J Immunol; 1986 Dec; 137(12):4016-20. PubMed ID: 3491154
[TBL] [Abstract][Full Text] [Related]
32. Variation in restriction fragment length and methylation pattern of rat MHC class I genes.
Uitterlinden AG; Vijg J; Giphart MJ; Knook DL
Exp Clin Immunogenet; 1985; 2(4):215-22. PubMed ID: 2908503
[TBL] [Abstract][Full Text] [Related]
33. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
Parmiani G
Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
[No Abstract] [Full Text] [Related]
34. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
Marzo AL; Lake RA; Robinson BW; Scott B
Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
[TBL] [Abstract][Full Text] [Related]
35. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
36. Structural relationships among the H-2 D-regions of murine MHC haplotypes.
Duran LW; Horton RM; Birschbach CW; Chang-Miller A; Pease LR
J Immunol; 1989 Jan; 142(1):288-96. PubMed ID: 2909618
[TBL] [Abstract][Full Text] [Related]
37. Nonclassical MHC-I and Japanese encephalitis virus infection: induction of H-2Q4, H-2T23 and H-2T10.
Abraham S; Yaddanapudi K; Thomas S; Damodaran A; Ramireddy B; Manjunath R
Virus Res; 2008 May; 133(2):239-49. PubMed ID: 18314211
[TBL] [Abstract][Full Text] [Related]
38. Activated c-K-ras and c-N-ras oncogenes in 3-methylcholanthrene-induced BALB/c fibrosarcomas.
Borrello MG; Carbone G; Pierotti MA; Molla A; Della Porta G
Carcinogenesis; 1988 Aug; 9(8):1517-9. PubMed ID: 3402050
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the class I MHC genes in the embryo and placenta during midgestational development in the mouse.
Hedley ML; Drake BL; Head JR; Tucker PW; Forman J
J Immunol; 1989 Jun; 142(11):4046-53. PubMed ID: 2715643
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
